Aktuellt
SENASTE
Q2 will likely be negatively affected by market turbulence weighing on Garantia's investment operations, given high exposure to fixed-income products. However, the underlying development most likely remained favourable for both Garantia and private asset management. Q2 earnings will be supported by Ficolo earn-outs, while the focus should be on any new information about the new flagship SolarWind III fund. Taaleri's first bioindustry fund achieved its first closing in Q2 at a targeted EUR 80m and fundraising has continued. We derive a fair value range of EUR 11.0-12.5 (11.7-13.7) per Taaleri share.
LÄS MER
